Literature DB >> 28250119

New Connections: Cell-to-Cell HIV-1 Transmission, Resistance to Broadly Neutralizing Antibodies, and an Envelope Sorting Motif.

S Abigail Smith1,2, Cynthia A Derdeyn3,2,4.   

Abstract

HIV-1 infection from cell-to-cell may provide an efficient mode of viral spread in vivo and could therefore present a significant challenge for preventative or therapeutic strategies based on broadly neutralizing antibodies. Indeed, Li et al. (H. Li, C. Zony, P. Chen, and B. K. Chen, J. Virol. 91:e02425-16, 2017, https://doi.org/10.1128/JVI.02425-16) showed that the potency and magnitude of multiple HIV-1 broadly neutralizing antibody classes are decreased during cell-to-cell infection in a context-dependent manner. A functional motif in gp41 appears to contribute to this differential susceptibility by modulating exposure of neutralization epitopes.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  broadly neutralizing antibody; human immunodeficiency virus; viral envelope; virological synapse

Mesh:

Substances:

Year:  2017        PMID: 28250119      PMCID: PMC5391458          DOI: 10.1128/JVI.00149-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Roles for endocytosis in lentiviral replication.

Authors:  M Marsh; A Pelchen-Matthews; J A Hoxie
Journal:  Trends Cell Biol       Date:  1997-01       Impact factor: 20.808

2.  Multiple proviral integration events after virological synapse-mediated HIV-1 spread.

Authors:  Rebecca A Russell; Nicola Martin; Ivonne Mitar; Emma Jones; Quentin J Sattentau
Journal:  Virology       Date:  2013-05-28       Impact factor: 3.616

3.  Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.

Authors:  Randi B Gombos; Dror Kolodkin-Gal; Leila Eslamizar; Joshua O Owuor; Emanuele Mazzola; Ana M Gonzalez; Birgit Korioth-Schmitz; Rebecca S Gelman; David C Montefiori; Barton F Haynes; Joern E Schmitz
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

4.  A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.

Authors:  Ryan J Park; Tim Wang; Dylan Koundakjian; Judd F Hultquist; Pedro Lamothe-Molina; Blandine Monel; Kathrin Schumann; Haiyan Yu; Kevin M Krupzcak; Wilfredo Garcia-Beltran; Alicja Piechocka-Trocha; Nevan J Krogan; Alexander Marson; David M Sabatini; Eric S Lander; Nir Hacohen; Bruce D Walker
Journal:  Nat Genet       Date:  2016-12-19       Impact factor: 38.330

Review 5.  Modeling mucosal cell-associated HIV type 1 transmission in vitro.

Authors:  Deborah J Anderson
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

6.  Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies.

Authors:  Irene A Abela; Livia Berlinger; Merle Schanz; Lucy Reynell; Huldrych F Günthard; Peter Rusert; Alexandra Trkola
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

7.  Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent.

Authors:  Lucia Reh; Carsten Magnus; Merle Schanz; Jacqueline Weber; Therese Uhr; Peter Rusert; Alexandra Trkola
Journal:  PLoS Pathog       Date:  2015-07-09       Impact factor: 6.823

8.  HIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per Cell.

Authors:  Mikaël Boullé; Thorsten G Müller; Sabrina Dähling; Yashica Ganga; Laurelle Jackson; Deeqa Mahamed; Lance Oom; Gila Lustig; Richard A Neher; Alex Sigal
Journal:  PLoS Pathog       Date:  2016-11-03       Impact factor: 6.823

9.  HIV-infected T cells are migratory vehicles for viral dissemination.

Authors:  Thomas T Murooka; Maud Deruaz; Francesco Marangoni; Vladimir D Vrbanac; Edward Seung; Ulrich H von Andrian; Andrew M Tager; Andrew D Luster; Thorsten R Mempel
Journal:  Nature       Date:  2012-08-01       Impact factor: 49.962

10.  Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission.

Authors:  Marine Malbec; Françoise Porrot; Rejane Rua; Joshua Horwitz; Florian Klein; Ari Halper-Stromberg; Johannes F Scheid; Caroline Eden; Hugo Mouquet; Michel C Nussenzweig; Olivier Schwartz
Journal:  J Exp Med       Date:  2013-11-25       Impact factor: 14.307

View more
  4 in total

1.  Single-Chain Variable Fragments of Broadly Neutralizing Antibodies Prevent HIV Cell-Cell Transmission.

Authors:  Rebecca T van Dorsten; Lucia Reh; Alexandra Trkola; Lynn Morris; Penny L Moore
Journal:  J Virol       Date:  2021-12-22       Impact factor: 6.549

2.  Viral cell-to-cell spread: Conventional and non-conventional ways.

Authors:  Nicolas Cifuentes-Munoz; Farah El Najjar; Rebecca Ellis Dutch
Journal:  Adv Virus Res       Date:  2020-09-29       Impact factor: 9.937

Review 3.  Emerging Targets for Developing T Cell-Mediated Vaccines for Human Immunodeficiency Virus (HIV)-1.

Authors:  Danushka K Wijesundara; Charani Ranasinghe; Branka Grubor-Bauk; Eric J Gowans
Journal:  Front Microbiol       Date:  2017-10-25       Impact factor: 5.640

4.  Synergistic inhibition of cell-to-cell HIV-1 infection by combinations of single chain variable fragments and fusion inhibitors.

Authors:  Mohammad Mamun Alam; Takeo Kuwata; Kazuki Tanaka; Muntasir Alam; Shokichi Takahama; Kazuya Shimura; Masao Matsuoka; Natsuki Fukuda; Hiroshi Morioka; Hirokazu Tamamura; Shuzo Matsushita
Journal:  Biochem Biophys Rep       Date:  2019-09-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.